Closed Systems Transfer Devices Market by Closing Mechanism, Type, Component, Technology, End User - Global Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 SCOPE-RELATED LIMITATIONS
  • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW
• 4.2 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY AND COUNTRY, 2024
• 4.3 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGIONAL MIX
• 4.4 CLOSED SYSTEM TRANSFER DEVICES MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
• 4.5 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing incidence of cancer and subsequent use of chemotherapy
    • 5.2.1.2 Increasing regulatory approvals for oncology therapeutics
    • 5.2.1.3 Rising awareness about risks associated with handling antineoplastic drugs
    • 5.2.1.4 Stringent regulatory guidelines for handling hazardous medication
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High implementation costs and limited reimbursements
    • 5.2.2.2 Inconsistent regulatory compliance
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth potential across therapeutic applications
    • 5.2.3.2 Rising healthcare expenditure in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Impact of closed system transfer devices on drug quality
    • 5.2.4.2 Low awareness and poor implementation of protective measures
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY COMPONENT
  • 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 RESEARCH & PRODUCT DEVELOPMENT
  • 5.5.2 MATERIAL COMPONENT PROCUREMENT AND MANUFACTURING
  • 5.5.3 MARKETING & SALES, SHIPMENT, AND AFTERSALES SERVICES
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Needle-free systems
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Integration of sensors
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Advancements in containments
• 5.10 INDUSTRY TRENDS
  • 5.10.1 INTEGRATION OF FILTERS IN CLOSED SYSTEM TRANSFER DEVICES
  • 5.10.2 AUTOMATION OF TRANSFER PROCESSES
  • 5.10.3 ADVANCED MATERIALS FOR DURABILITY AND COMPATIBILITY WITH COMPLEX DRUG FORMULATIONS
• 5.11 PATENT ANALYSIS
• 5.12 TRADE DATA ANALYSIS
  • 5.12.1 IMPORT DATA
  • 5.12.2 EXPORT DATA
• 5.13 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.14 CASE STUDY ANALYSIS
  • 5.14.1 CASE STUDY 1: EXTENSION OF BEYOND-USE DATE OF SINGLE-DOSE VIALS AT MOUNT SINAI HOSPITAL
  • 5.14.2 CASE STUDY 2: ENHANCED SAFETY AND EFFICIENCY OF DRUG COMPOUNDING AT NEBRASKA METHODIST HOSPITAL
  • 5.14.3 CASE STUDY 3: PREVENTION OF MICROBIAL CONTAMINATION DURING SIMULATED WORST-CASE SCENARIOS
• 5.15 REGULATORY LANDSCAPE
  • 5.15.1 REGULATORY STANDARDS AND APPROVALS
    • 5.15.1.1 US
      • 5.15.1.1.1 USP <800> Regulations
      • 5.15.1.1.2 National Institute for Occupational Safety and Health
      • 5.15.1.1.3 American Society of Health-System Pharmacists
      • 5.15.1.1.4 International Society of Oncology Pharmacy Practitioners
    • 5.15.1.2 European Union
  • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.16 PORTER'S FIVE FORCES ANALYSIS
  • 5.16.1 BARGAINING POWER OF SUPPLIERS
  • 5.16.2 BARGAINING POWER OF BUYERS
  • 5.16.3 THREAT OF NEW ENTRANTS
  • 5.16.4 THREAT OF SUBSTITUTES
  • 5.16.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.2 BUYING CRITERIA
• 5.18 UNMET NEEDS/END-USER EXPECTATIONS
• 5.19 IMPACT OF GEN AI ON CLOSED SYSTEM TRANSFER DEVICES MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 MARKET POTENTIAL OF AI IN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET
  • 5.19.3 AI USE CASES
  • 5.19.4 KEY COMPANIES IMPLEMENTING AI
  • 5.19.5 FUTURE OF GENERATIVE AI IN CLOSED SYSTEM TRANSFER DEVICES MARKET
• 5.20 IMPACT OF US TARIFF REGULATION ON CLOSED SYSTEM TRANSFER DEVICES MARKET
  • 5.20.1 NORTH AMERICA
  • 5.20.2 EUROPE
  • 5.20.3 ASIA PACIFIC
  • 5.20.4 LATIN AMERICA
  • 5.20.5 MIDDLE EAST & AFRICA

6 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM

• 6.1 INTRODUCTION
• 6.2 LUER LOCK SYSTEMS
  • 6.2.1 GROWING PREVALENCE OF INJECTABLE DRUGS TO PROPEL MARKET
• 6.3 PUSH-TO-TURN SYSTEMS
  • 6.3.1 INCREASING FOCUS ON COMPLYING WITH REGULATIONS AND GUIDELINES FOR SAFE HANDLING OF DRUGS TO AID GROWTH
• 6.4 CLICK-TO-LOCK SYSTEMS
  • 6.4.1 LOW IMPLEMENTATION COST TO CONTRIBUTE TO GROWTH
• 6.5 COLOR-TO-COLOR ALIGNMENT SYSTEMS
  • 6.5.1 GROWING FOCUS ON CURBING RISK OF MEDICATION ERRORS TO FUEL MARKET

7 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 MEMBRANE-TO-MEMBRANE SYSTEMS
  • 7.2.1 INCREASING FOCUS ON SAFEGUARDING HEALTH AND WELL-BEING OF HEALTHCARE PROVIDERS TO EXPEDITE GROWTH
• 7.3 NEEDLELESS SYSTEMS
  • 7.3.1 EVOLVING MEDICAL DEVICE TECHNOLOGY LANDSCAPE TO STIMULATE GROWTH

8 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT

• 8.1 INTRODUCTION
• 8.2 VIAL ACCESS COMPONENTS
  • 8.2.1 GROWING CONCERNS SURROUNDING HEALTHCARE-ASSOCIATED INFECTIONS TO DRIVE MARKET
• 8.3 MALE LUERS
  • 8.3.1 NEED TO PREVENT AIR EMBOLISM AND PRESERVE INTEGRITY OF INTRAVENOUS SYSTEMS TO PROMOTE GROWTH
• 8.4 BAG SPIKES
  • 8.4.1 GROWING FOCUS ON ENHANCED SAFETY, EFFICIENCY, AND PRECISION IN HANDLING AND ADMINISTRATING HAZARDOUS DRUGS TO BOOST MARKET
• 8.5 FEMALE COMPONENTS
  • 8.5.1 NEED TO PREVENT CONTAMINATION OF DRUGS AND EQUIPMENT TO ENCOURAGE GROWTH
• 8.6 OTHER COMPONENTS

9 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY

• 9.1 INTRODUCTION
• 9.2 DIAPHRAGM-BASED DEVICES
  • 9.2.1 INCREASING USE OF DIAPHRAGM-BASED DEVICES IN CHEMOTHERAPY AND OTHER ONCOLOGY TREATMENTS TO FOSTER GROWTH
• 9.3 COMPARTMENTALIZED DEVICES
  • 9.3.1 NEED TO MAINTAIN INTEGRITY OF MEDICATIONS DURING TRANSFER TO SUSTAIN GROWTH
• 9.4 AIR CLEANING/FILTRATION DEVICES
  • 9.4.1 NEED FOR CLEAN AND STERILE ENVIRONMENT WITHIN PHARMACEUTICAL AND HEALTHCARE FACILITIES TO FACILITATE GROWTH

10 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS & CLINICS
  • 10.2.1 GROWING FOCUS ON ENHANCED STAFF AND PATIENT SAFETY IN HEALTHCARE SETTINGS TO BOOST MARKET
• 10.3 ONCOLOGY CENTERS
  • 10.3.1 NEED TO MINIMIZE RISK OF OCCUPATIONAL EXPOSURE TO AUGMENT GROWTH
• 10.4 OTHER END USERS

11 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Rising focus on best practice recommendations and mandates for healthcare workers to aid growth
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing demand for antineoplastic drugs to assist growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Growing emphasis on healthcare protocols to propel market
  • 11.3.3 UK
    • 11.3.3.1 Strict guidelines for handling hazardous drugs to promote growth
  • 11.3.4 FRANCE
    • 11.3.4.1 High healthcare expenditure to accelerate growth
  • 11.3.5 SPAIN
    • 11.3.5.1 Increasing incidence of cancer to favor growth
  • 11.3.6 ITALY
    • 11.3.6.1 Rising geriatric population and subsequent prevalence of chronic diseases to aid growth
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Established healthcare system and rising geriatric population to drive market
  • 11.4.3 CHINA
    • 11.4.3.1 Large target patient population to stimulate growth
  • 11.4.4 INDIA
    • 11.4.4.1 Rising adoption of chemotherapy procedures to facilitate growth
  • 11.4.5 AUSTRALIA AND NEW ZEALAND
    • 11.4.5.1 Rising incidence of chronic diseases to speed up growth
  • 11.4.6 SOUTH KOREA
    • 11.4.6.1 Shift to aging demography to spur growth
  • 11.4.7 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Booming healthcare and pharmaceutical sectors to amplify growth
  • 11.5.3 MEXICO
    • 11.5.3.1 Rising initiatives on universal healthcare coverage to support growth
  • 11.5.4 COLOMBIA
    • 11.5.4.1 Growing prioritization of patient and worker safety to bolster growth
  • 11.5.5 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Higher disposable incomes to expedite growth
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 12.3 REVENUE ANALYSIS, 2020-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
• 12.5 R&D ASSESSMENT OF KEY PLAYERS
• 12.6 COMPANY VALUATION AND FINANCIAL METRICES
• 12.7 BRAND/PRODUCT COMPARISON
  • 12.7.1.1 BD
  • 12.7.1.2 ICU Medical, Inc.
  • 12.7.1.3 B. Braun Melsungen AG
  • 12.7.1.4 JMS Co. Ltd.
  • 12.7.1.5 Baxter
  • 12.7.1.6 EQUASHIELD
• 12.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.8.1 STARS
  • 12.8.2 EMERGING LEADERS
  • 12.8.3 PERVASIVE PLAYERS
  • 12.8.4 PARTICIPANTS
  • 12.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.8.5.1 Company footprint
    • 12.8.5.2 Region footprint
    • 12.8.5.3 Closing mechanism footprint
    • 12.8.5.4 Type footprint
    • 12.8.5.5 Component footprint
    • 12.8.5.6 Technology footprint
    • 12.8.5.7 End-user footprint
• 12.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.9.1 PROGRESSIVE COMPANIES
  • 12.9.2 RESPONSIVE COMPANIES
  • 12.9.3 DYNAMIC COMPANIES
  • 12.9.4 STARTING BLOCKS
  • 12.9.5 COMPETITIVE BENCHMARKING
    • 12.9.5.1 Detailed list of key startups/SMEs
    • 12.9.5.2 Competitive benchmarking of key startups/SMEs
• 12.10 COMPETITIVE SCENARIO
  • 12.10.1 PRODUCT LAUNCHES AND APPROVALS
  • 12.10.2 DEALS
  • 12.10.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 BD
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 ICU MEDICAL, INC.
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 B. BRAUN MELSUNGEN AG
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches and approvals
      • 13.1.3.3.2 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 JMS CO. LTD.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 MnM view
      • 13.1.4.3.1 Right to win
      • 13.1.4.3.2 Strategic choices
      • 13.1.4.3.3 Weaknesses and competitive threats
  • 13.1.5 BAXTER
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses and competitive threats
  • 13.1.6 WEST PHARMACEUTICAL SERVICES, INC.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Expansions
  • 13.1.7 TERUMO CORPORATION
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Expansions
  • 13.1.8 CARDINAL HEALTH
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
  • 13.1.9 EQUASHIELD
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches and approvals
      • 13.1.9.3.2 Deals
  • 13.1.10 SIMPLIVIA HEALTHCARE LTD.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Deals
  • 13.1.11 YUKON MEDICAL
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
  • 13.1.12 CODAN MEDIZINISCHE GERATE GMBH
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
  • 13.1.13 VYGON
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Deals
  • 13.1.14 ELCAM MEDICAL
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
  • 13.1.15 PRACTIVET, INC.
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
• 13.2 OTHER COMPANIES
  • 13.2.1 CARAGEN
  • 13.2.2 CORVIDA MEDICAL
  • 13.2.3 VICTUS
  • 13.2.4 EPIC SYSTEMS CORPORATIONS
  • 13.2.5 ERASER MEDICAL
  • 13.2.6 NEEDLELESS CORPORATION
  • 13.2.7 AMSINO INTERNATIONAL, INC.
  • 13.2.8 INSUNG MEDICAL CO., LTD.
  • 13.2.9 ADVCARE MEDICAL, INC.
  • 13.2.10 SHANDONG ANDE HEALTHCARE APPARATUS CO., LTD.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

List of Tables

• TABLE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET: INCLUSIONS AND EXCLUSIONS
• TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021-2024
• TABLE 3 CLOSED SYSTEM TRANSFER DEVICES MARKET: RISK ASSESSMENT ANALYSIS
• TABLE 4 NATIONAL/LOCAL REGULATORY BODIES RECOMMENDING CLOSED SYSTEM TRANSFER DEVICES FOR MEDICATION HANDLING, BY COUNTRY
• TABLE 5 CLOSED SYSTEM TRANSFER DEVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
• TABLE 6 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES, BY COMPONENT, 2022-2024
• TABLE 7 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES, BY KEY PLAYER, 2022-2024
• TABLE 8 AVERAGE SELLING TREND OF CLOSED SYSTEM TRANSFER COMPONENTS, BY REGION, 2022-2024
• TABLE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
• TABLE 11 IMPORT DATA FOR HS CODE 901890 BY COUNTRY, 2020-2024 (USD THOUSAND)
• TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020-2024 (USD THOUSAND)
• TABLE 13 CLOSED SYSTEM TRANSFER DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
• TABLE 14 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH: CLASSIFICATION OF HAZARDOUS DRUGS
• TABLE 15 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH: HAZARDOUS DRUG ADMINISTRATION RECOMMENDATIONS AND USP 800 REQUIREMENTS
• TABLE 16 NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH AND AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS: DEFINITIONS FOR HAZARDOUS DRUGS
• TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 22 CLOSED SYSTEM TRANSFER DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TECHNOLOGIES (%)
• TABLE 24 KEY BUYING CRITERIA FOR TOP THREE TECHNOLOGIES
• TABLE 25 KEY COMPANIES IMPLEMENTING AI
• TABLE 26 CLOSING MECHANISMS AVAILABLE IN CLOSED SYSTEM TRANSFER DEVICES
• TABLE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 28 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR LUER LOCK SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 29 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR PUSH-TO-TURN SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 30 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR CLICK-TO-LOCK SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 31 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR COLOR-TO-COLOR ALIGNMENT SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 33 LEADING MANUFACTURERS OF MEMBRANE-TO-MEMBRANE SYSTEMS
• TABLE 34 MEMBRANE-TO-MEMBRANE CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 35 LEADING MANUFACTURERS OF NEEDLELESS SYSTEMS
• TABLE 36 NEEDLELESS CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 37 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 38 VIAL ACCESS COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES
• TABLE 39 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS COMPONENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 40 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR VIAL ACCESS COMPONENTS, BY REGION, 2023-2030 (THOUSAND UNITS)
• TABLE 41 MALE LUERS FOR CLOSED SYSTEM TRANSFER DEVICES
• TABLE 42 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR MALE LUERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 43 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR MALE LUERS, BY REGION, 2023-2030 (THOUSAND UNITS)
• TABLE 44 BAG SPIKE COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES
• TABLE 45 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG SPIKES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR BAG SPIKES, BY REGION, 2021-2029 (THOUSAND UNITS)
• TABLE 47 FEMALE COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES
• TABLE 48 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR FEMALE COMPONENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 49 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR FEMALE COMPONENTS, BY REGION, 2023-2030 (THOUSAND UNITS)
• TABLE 50 OTHER COMPONENTS FOR CLOSED SYSTEM TRANSFER DEVICES
• TABLE 51 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER COMPONENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 52 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 53 DIAPHRAGM-BASED DEVICES AVAILABLE IN MARKET
• TABLE 54 DIAPHRAGM-BASED CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 55 COMPARTMENTALIZED DEVICES AVAILABLE IN MARKET
• TABLE 56 COMPARTMENTALIZED CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 57 AIR CLEANING/FILTRATION DEVICES AVAILABLE IN MARKET
• TABLE 58 AIR CLEANING/FILTRATION CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 59 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 60 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 61 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR ONCOLOGY CENTERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 62 CLOSED SYSTEM TRANSFER DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 63 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 64 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 65 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 66 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 67 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 68 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 69 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 70 US: KEY MACROECONOMIC INDICATORS
• TABLE 71 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 72 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 73 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 74 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 75 US: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 76 CANADA: KEY MACROECONOMIC INDICATORS
• TABLE 77 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 78 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 79 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 80 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 81 CANADA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 82 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 83 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 84 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 85 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 86 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 87 EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 88 GERMANY: KEY MACROECONOMIC INDICATORS
• TABLE 89 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 90 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 91 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 92 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 93 GERMANY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 94 UK: KEY MACROECONOMIC INDICATORS
• TABLE 95 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 96 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 97 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 98 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 99 UK: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 100 FRANCE: KEY MACROECONOMIC INDICATORS
• TABLE 101 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 102 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 103 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 104 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 105 FRANCE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 106 SPAIN: KEY MACROECONOMIC INDICATORS
• TABLE 107 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 108 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 109 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 110 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 111 SPAIN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 112 ITALY: KEY MACROECONOMIC INDICATORS
• TABLE 113 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 114 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 115 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 116 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 117 ITALY: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 118 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 119 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 120 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 121 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 122 REST OF EUROPE: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 123 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 124 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 125 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 126 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 127 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 128 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 129 JAPAN: KEY MACROECONOMIC INDICATORS
• TABLE 130 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 131 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 132 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 133 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 134 JAPAN: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 135 CHINA: KEY MACROECONOMIC INDICATORS
• TABLE 136 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 137 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 138 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 139 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 140 CHINA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 141 INDIA: KEY MACROECONOMIC INDICATORS
• TABLE 142 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 143 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 144 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 145 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 146 INDIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 147 AUSTRALIA: KEY MACROECONOMIC INDICATORS
• TABLE 148 NEW ZEALAND: KEY MACROECONOMIC INDICATORS
• TABLE 149 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 150 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 151 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 152 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 153 AUSTRALIA AND NEW ZEALAND: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 154 SOUTH KOREA: KEY MACROECONOMIC INDICATORS
• TABLE 155 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 156 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 157 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 158 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 159 SOUTH KOREA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 160 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 161 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 162 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 163 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 164 REST OF ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 165 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 166 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 167 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 168 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 169 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 170 LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 171 BRAZIL: KEY MACROECONOMIC INDICATORS
• TABLE 172 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 173 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 174 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 175 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 176 BRAZIL: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 177 MEXICO: KEY MACROECONOMIC INDICATORS
• TABLE 178 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 179 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 180 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 181 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 182 MEXICO: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 183 COLOMBIA: KEY MACROECONOMIC INDICATORS
• TABLE 184 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 185 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 186 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 187 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 188 COLOMBIA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 189 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 190 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 191 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 192 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 193 REST OF LATIN AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 194 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 195 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 196 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 197 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 198 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 199 MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 200 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 201 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 202 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 203 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 204 GCC COUNTRIES: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 205 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2023-2030 (USD MILLION)
• TABLE 206 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 207 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
• TABLE 208 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 209 REST OF MIDDLE EAST & AFRICA: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 210 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, JANUARY 2022-MARCH 2025
• TABLE 211 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEGREE OF COMPETITION
• TABLE 212 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGION FOOTPRINT
• TABLE 213 CLOSED SYSTEM TRANSFER DEVICES MARKET: CLOSING MECHANISM FOOTPRINT
• TABLE 214 CLOSED SYSTEM TRANSFER DEVICES MARKET: TYPE FOOTPRINT
• TABLE 215 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPONENT FOOTPRINT
• TABLE 216 CLOSED SYSTEM TRANSFER DEVICES MARKET: TECHNOLOGY FOOTPRINT
• TABLE 217 CLOSED SYSTEM TRANSFER DEVICES MARKET: END-USER FOOTPRINT
• TABLE 218 CLOSED SYSTEM TRANSFER DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
• TABLE 219 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
• TABLE 220 CLOSED SYSTEM TRANSFER DEVICES MARKET: PRODUCT LAUNCHES A ND APPROVALS, JANUARY 2021-MARCH 2025
• TABLE 221 CLOSED SYSTEM TRANSFER DEVICES MARKET: DEALS, JANUARY 2021-MARCH 2025
• TABLE 222 CLOSED SYSTEM TRANSFER DEVICES MARKET: EXPANSIONS, JANUARY 2021-MARCH 2025
• TABLE 223 BD: COMPANY OVERVIEW
• TABLE 224 BD: PRODUCTS OFFERED
• TABLE 225 BD: EXPANSIONS, JANUARY 2021-MARCH 2025
• TABLE 226 ICU MEDICAL, INC.: COMPANY OVERVIEW
• TABLE 227 ICU MEDICAL, INC.: PRODUCTS OFFERED
• TABLE 228 ICU MEDICAL, INC.: DEALS, JANUARY 2021-MARCH 2025
• TABLE 229 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
• TABLE 230 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED
• TABLE 231 B. BRAUN MELSUNGEN AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MARCH 2025
• TABLE 232 B. BRAUN MELSUNGEN AG: EXPANSIONS, JANUARY 2021-MARCH 2025
• TABLE 233 JMS CO. LTD.: COMPANY OVERVIEW
• TABLE 234 JMS CO. LTD.: PRODUCTS OFFERED
• TABLE 235 BAXTER: COMPANY OVERVIEW
• TABLE 236 BAXTER: PRODUCTS OFFERED
• TABLE 237 BAXTER: DEALS, JANUARY 2021-MARCH 2025
• TABLE 238 WEST PHARMACEUTICAL SERVICES, INC: COMPANY OVERVIEW
• TABLE 239 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS OFFERED
• TABLE 240 WEST PHARMACEUTICAL SERVICES, INC.: EXPANSIONS, JANUARY 2021-MARCH 2025
• TABLE 241 TERUMO CORPORATION: COMPANY OVERVIEW
• TABLE 242 TERUMO CORPORATION: PRODUCTS OFFERED
• TABLE 243 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021-MARCH 2024
• TABLE 244 CARDINAL HEALTH: COMPANY OVERVIEW
• TABLE 245 CARDINAL HEALTH: PRODUCTS OFFERED
• TABLE 246 EQUASHIELD: COMPANY OVERVIEW
• TABLE 247 EQUASHIELD: PRODUCTS OFFERED
• TABLE 248 EQUASHIELD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-MARCH 2025
• TABLE 249 EQUASHIELD: DEALS, JANUARY 2021-MARCH 2025
• TABLE 250 SIMPLIVIA HEALTHCARE LTD.: COMPANY OVERVIEW
• TABLE 251 SIMPLVIA HEALTHCARE LTD.: PRODUCTS OFFERED
• TABLE 252 SIMPLVIA HEALTHCARE LTD.: DEALS, JANUARY 2021-MARCH 2025
• TABLE 253 YUKON MEDICAL: COMPANY OVERVIEW
• TABLE 254 YUKON MEDICAL: PRODUCTS OFFERED
• TABLE 255 CODAN MEDIZINISCHE GERATE GMBH: COMPANY OVERVIEW
• TABLE 256 CODAN MEDIZINISCHE GERATE GMBH: PRODUCTS OFFERED
• TABLE 257 VYGON: COMPANY OVERVIEW
• TABLE 258 VYGON: PRODUCTS OFFERED
• TABLE 259 VYGON: DEALS, JANUARY 2021-MARCH 2025
• TABLE 260 ELCAM MEDICAL: COMPANY OVERVIEW
• TABLE 261 ELCAM MEDICAL: PRODUCTS OFFERED
• TABLE 262 PRACTIVET, INC.: COMPANY OVERVIEW
• TABLE 263 PRACTIVET, INC.: PRODUCTS OFFERED
• TABLE 264 CARAGEN: COMPANY OVERVIEW
• TABLE 265 CORVIDA MEDICAL: COMPANY OVERVIEW
• TABLE 266 VICTUS: COMPANY OVERVIEW
• TABLE 267 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
• TABLE 268 ERASER MEDICAL: COMPANY OVERVIEW
• TABLE 269 NEEDLELESS CORPORATION: COMPANY OVERVIEW
• TABLE 270 AMSINO INTERNATIONAL, INC.: COMPANY OVERVIEW
• TABLE 271 INSUNG MEDICAL CO., LTD.: COMPANY OVERVIEW
• TABLE 272 ADVCARE MEDICAL, INC.: COMPANY OVERVIEW
• TABLE 273 SHANDONG ANDE HEALTHCARE APPARATUS CO., LTD.: COMPANY OVERVIEW

List of Figures

• FIGURE 1 CLOSED SYSTEM TRANSFER DEVICES MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 RESEARCH DESIGN
• FIGURE 3 PRIMARY SOURCES
• FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
• FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
• FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
• FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF ICU MEDICAL, INC., 2024
• FIGURE 9 CLOSED SYSTEM TRANSFER DEVICES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION
• FIGURE 10 CLOSED SYSTEM TRANSFER DEVICES MARKET: BOTTOM-UP APPROACH
• FIGURE 11 CLOSED SYSTEM TRANSFER DEVICE MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH FOR US MARKET
• FIGURE 12 CLOSED SYSTEM TRANSFER DEVICES MARKET: TOP-DOWN APPROACH
• FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024-2029
• FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 15 DATA TRIANGULATION METHODOLOGY
• FIGURE 16 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY CLOSING MECHANISM, 2025 VS. 2030 (USD MILLION)
• FIGURE 17 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
• FIGURE 18 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY COMPONENT, 2025 VS. 2030 (USD MILLION)
• FIGURE 19 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
• FIGURE 20 CLOSED SYSTEM TRANSFER DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 21 GEOGRAPHIC SNAPSHOT OF CLOSED SYSTEM TRANSFER DEVICES MARKET
• FIGURE 22 RISING INCIDENCE OF CANCER AND SUBSEQUENT USE OF CHEMOTHERAPY TO DRIVE MARKET
• FIGURE 23 DIAPHRAGM-BASED DEVICES SEGMENT AND JAPAN LED ASIA PACIFIC CLOSED SYSTEM TRANSFER DEVICES MARKET IN 2024
• FIGURE 24 NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
• FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
• FIGURE 26 CHINA TO GROW AT HIGHEST GROWTH CAGR DURING FORECAST PERIOD
• FIGURE 27 CLOSED SYSTEM TRANSFER DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 28 NEW REVENUE POCKETS FOR PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET
• FIGURE 29 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES, BY COMPONENT, 2022-2024
• FIGURE 30 AVERAGE SELLING PRICE TREND OF CLOSED SYSTEM TRANSFER DEVICES, BY KEY PLAYER, 2022-2024 (USD)
• FIGURE 31 AVERAGE SELLING PRICE OF CLOSED SYSTEM TRANSFER COMPONENTS, BY REGION, 2022-2024 (USD)
• FIGURE 32 CLOSED SYSTEM TRANSFER DEVICES MARKET: VALUE CHAIN ANALYSIS
• FIGURE 33 CLOSED SYSTEM TRANSFER DEVICES MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 34 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
• FIGURE 35 INVESTMENT AND FUNDING SCENARIO, 2019-2023
• FIGURE 36 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
• FIGURE 37 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023 (USD MILLION)
• FIGURE 38 PATENT ANALYSIS, JANUARY 2015-MARCH 2025
• FIGURE 39 IMPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
• FIGURE 40 EXPORT DATA FOR HS CODE 901890 COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024
• FIGURE 41 PORTER'S FIVE FORCES ANALYSIS
• FIGURE 42 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TECHNOLOGIES
• FIGURE 43 KEY BUYING CRITERIA FOR TOP THREE TECHNOLOGIES
• FIGURE 44 AI USE CASES
• FIGURE 45 CLOSED SYSTEM TRANSFER DEVICE PRICING PER UNIT, BY VENDOR
• FIGURE 46 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• FIGURE 47 NORTH AMERICA: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT
• FIGURE 48 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET SNAPSHOT
• FIGURE 49 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, 2020-2024
• FIGURE 50 CLOSED SYSTEM TRANSFER DEVICES MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
• FIGURE 51 R&D EXPENDITURE OF KEY PLAYERS IN CLOSED SYSTEM TRANSFER DEVICES MARKET, 2022 VS. 2023
• FIGURE 52 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
• FIGURE 53 EV/EBITDA OF KEY VENDORS
• FIGURE 54 CLOSED SYSTEM TRANSFER DEVICES MARKET: BRAND/PRODUCT COMPARISON
• FIGURE 55 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 56 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY FOOTPRINT
• FIGURE 57 CLOSED SYSTEM TRANSFER DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 58 BD: COMPANY SNAPSHOT (2024)
• FIGURE 59 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 60 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2023)
• FIGURE 61 JMS CO. LTD.: COMPANY SNAPSHOT (2024)
• FIGURE 62 BAXTER: COMPANY SNAPSHOT (2024)
• FIGURE 63 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 64 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 65 CARDINAL HEALTH: COMPANY SNAPSHOT (2024)